Company logo

IDYA - IDEAYA Biosciences, Inc.

NASDAQ -> Healthcare -> Biotechnology
South San Francisco, United States
Type: Equity

IDYA price evolution
IDYA
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $157.78 $152.57 $103.56 $67.34
Short term investments $368.1 $316.9 $390.87 $272.23
Net receivables $0.02 $6.7 $0.16 $0.47
Inventory
Total current assets $532.63 $482.18 $501.79 $343.96
Long term investments $107.49 $42.39 $16.38 $11.74
Property, plant & equipment $8.41 $7.54 $8.56 $8.83
Goodwill & intangible assets
Total noncurrent assets $116.68 $50.76 $25.77 $20.79
Total investments $475.59 $359.3 $407.25 $283.97
Total assets $649.32 $532.94 $527.56 $364.75
Current liabilities
Accounts payable $6.6 $5.17 $5.87 $4.38
Deferred revenue
Short long term debt $1.75 $2.1 $1.96 $1.92
Total current liabilities $27.1 $24.89 $25.34 $29.82
Long term debt $1.13 $0.61 $1.12
Total noncurrent liabilities $1.13 $0.61 $1.12
Total debt $2.87 $2.1 $2.57 $3.03
Total liabilities $28.23 $24.89 $25.95 $30.94
Shareholders' equity
Retained earnings -$348.36 -$314.41 -$286.97 -$259.04
Other shareholder equity $0.56 -$0.75 -$1.18 -$1.41
Total shareholder equity $621.09 $508.05 $501.61 $333.81
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $157.78 $68.74 $92.15 $72.14
Short term investments $368.1 $296.2 $154.72 $211.55
Net receivables $0.02 $0.21 $1.1 $1.88
Inventory
Total current assets $532.63 $370.45 $251 $288.61
Long term investments $107.49 $8.32 $121.29
Property, plant & equipment $8.41 $8.99 $8.66 $9.48
Goodwill & intangible assets
Total noncurrent assets $116.68 $17.52 $130.35 $9.66
Total investments $475.59 $304.51 $276.02 $211.55
Total assets $649.32 $387.97 $381.35 $298.27
Current liabilities
Accounts payable $6.6 $4.28 $2.1 $0.95
Deferred revenue
Short long term debt $1.75 $1.87 $1.7 $1.54
Total current liabilities $27.1 $31.72 $45.16 $38.64
Long term debt $1.13 $1.61 $3.48 $5.18
Total noncurrent liabilities $1.13 $6.8 $34.67 $61.35
Total debt $2.87 $3.48 $5.18 $6.72
Total liabilities $28.23 $38.51 $79.83 $100
Shareholders' equity
Retained earnings -$348.36 -$235.4 -$176.75 -$126.99
Other shareholder equity $0.56 -$2.87 -$0.71 $0.01
Total shareholder equity $621.09 $349.45 $301.51 $198.27
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $3.92 $8.04 $3.54 $7.88
Cost of revenue
Gross Profit $3.92 $8.04 $3.54 $7.88
Operating activities
Research & development $38.77 $33.7 $29.18 $27.86
Selling, general & administrative $7.07 $7.86 $7.08 $6.3
Total operating expenses $45.84 $41.56 $36.25 $34.16
Operating income -$41.92 -$33.53 -$32.71 -$26.28
Income from continuing operations
EBIT -$33.95 -$27.44 -$27.93 -$23.64
Income tax expense
Interest expense
Net income
Net income -$33.95 -$27.44 -$27.93 -$23.64
Income (for common shares) -$33.95 -$27.44 -$27.93 -$23.64
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $23.39 $50.93 $27.94 $19.54
Cost of revenue
Gross Profit $23.39 $50.93 $27.94 $19.54
Operating activities
Research & development $129.51 $89.54 $58.16 $39.7
Selling, general & administrative $28.31 $23.9 $20.05 $15.18
Total operating expenses $157.81 $113.43 $78.21 $54.88
Operating income -$134.43 -$62.5 -$50.27 -$35.34
Income from continuing operations
EBIT -$112.96 -$58.66 -$49.76 -$34.49
Income tax expense
Interest expense
Net income
Net income -$112.96 -$58.66 -$49.76 -$34.49
Income (for common shares) -$112.96 -$58.66 -$49.76 -$34.49
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$33.95 -$27.44 -$27.93 -$23.64
Operating activities
Depreciation $1.02 $1.03 $1 $0.96
Business acquisitions & disposals
Stock-based compensation $4.8 $5.3 $4.73 $3.66
Total cash flows from operations -$23.75 -$30.17 -$33.46 -$27.84
Investing activities
Capital expenditures -$0.84 -$0.6 -$0.88 -$0.04
Investments -$111.11 $51.95 -$120.5 $23.56
Total cash flows from investing -$111.94 $51.35 -$121.38 $23.52
Financing activities
Dividends paid
Sale and purchase of stock $98.71 $27.83 $191.06 $2.93
Net borrowings
Total cash flows from financing $140.89 $27.83 $191.06 $2.93
Effect of exchange rate
Change in cash and equivalents $5.2 $49.01 $36.22 -$1.4
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$112.96 -$58.66 -$49.76 -$34.49
Operating activities
Depreciation $4.01 $2.1 $1.73 $1.38
Business acquisitions & disposals
Stock-based compensation $18.49 $11.63 $8.24 $3.61
Total cash flows from operations -$115.22 -$87.17 -$55.78 $55.46
Investing activities
Capital expenditures -$2.37 -$3.44 -$2.64 -$0.49
Investments -$156.09 -$29.96 -$67.02 -$145.75
Total cash flows from investing -$158.46 -$33.4 -$69.67 -$146.24
Financing activities
Dividends paid
Sale and purchase of stock $320.54 $97.17 $145.45 $128.75
Net borrowings
Total cash flows from financing $362.72 $97.17 $145.45 $128.75
Effect of exchange rate
Change in cash and equivalents $89.04 -$23.41 $20.01 $37.97
Fundamentals
Market cap $2.82B
Enterprise value $2.66B
Shares outstanding 65.04M
Revenue $23.38M
EBITDA -$108.95M
EBIT -$112.96M
Net Income -$112.96M
Revenue Q/Q -2.49%
Revenue Y/Y -54.09%
P/E ratio -24.94
EV/Sales 113.84
EV/EBITDA -24.43
EV/EBIT -23.57
P/S ratio 120.46
P/B ratio 4.54
Book/Share 9.54
Cash/Share 2.43
EPS -$1.74
ROA -21.78%
ROE -23.00%
Debt/Equity 0.05
Net debt/EBITDA 1.19
Current ratio 19.65
Quick ratio 19.65